Results 111 to 120 of about 356 (173)

Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study. [PDF]

open access: yesDiabetol Int, 2018
Nunome H   +11 more
europepmc   +1 more source

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study. [PDF]

open access: yesDiabetol Int, 2018
Ujihara N   +11 more
europepmc   +1 more source

Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial. [PDF]

open access: yesEClinicalMedicine
Zhou J   +20 more
europepmc   +1 more source

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. [PDF]

open access: yesN Engl J Med
EMPA-KIDNEY Collaborative Group   +41 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy